Cabbacis Inc has filed a qualification statement that allows the company to proceed with its planned offerings. This filing is significant as it indicates the company's readiness to engage with investors and expand its operations in the tobacco products industry.
Background
Cabbacis Inc, categorized under the Tobacco Products industry (SIC: 2100), is incorporated in Nevada. The company has been actively filing various forms with the SEC, including recent submissions like the 1-A POS and 1-U. This filing, dated October 29, 2026, marks a critical step in its business strategy.
What the Filing Says
The filing states that the qualification is effective as of October 29, 2026. It allows Cabbacis Inc to move forward with its offerings, which could include securities intended for public sale.
Impact
This development may affect potential investors and stakeholders in Cabbacis Inc, as well as competitors in the tobacco products sector. The filing reflects Cabbacis' intentions to grow and adapt in a competitive market.
What's Next
The filing does not say what happens next.
Company Details
Cabbacis Inc is organized under the name 04 Manufacturing and has a Central Index Key (CIK) of 0001987010. The company's Employer Identification Number (EIN) is 932432982, and it is incorporated in the state of Nevada. The fiscal year for Cabbacis Inc ends on December 31st.
Contact Information
The business address for Cabbacis Inc is 3193 Buffalo Avenue, Unit 1, Niagara Falls, NY 14303. For inquiries, the company can be reached at the business phone number 716-320-5525. Additionally, the mailing address is listed as 7954 Transit Road, No. 316, Williamsville, NY 14221.
Filing Context
This qualification statement falls under the Securities Act of 1933, specifically related to the SEC File Number 024-12621. The filing was accepted on October 30, 2026, and is part of Cabbacis Inc's ongoing compliance with SEC regulations.
Additional Information
The filing does not include specific details regarding the types of securities that will be offered or the intended use of proceeds from the offerings. There is also no mention of potential risks associated with the investment or any forward-looking statements regarding the company’s future performance.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










